Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.

@article{Videtic2003ShiftingFH,
  title={Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.},
  author={Gregory M. M. Videtic and Pauline T. Truong and A. Rashid Dar and Edward W Yu and Larry W. Stitt},
  journal={International journal of radiation oncology, biology, physics},
  year={2003},
  volume={57 3},
  pages={709-16}
}
PURPOSE To perform a retrospective review of a single institution's 10-year experience in treating limited-stage small-cell lung cancer (LS-SCLC) with a concurrent chemoradiation regimen modeled after the experimental arm of a randomized National Cancer Institute of Canada trial in which hypofractionated radiotherapy started with cycle 2 of chemotherapy. We then looked at the impact on patient outcomes of changing the RT during the course of the decade to a "conventionally" (2 Gy) fractionated… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Radiochemotherapy for lung cancer in developing countries.

Clinical oncology (Royal College of Radiologists (Great Britain)) • 2009

Similar Papers

Loading similar papers…